Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 12Unknown 4Suspended 1

Sponsor Class

NIH 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Inflammatory Breast Neoplasms 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × CMF regimen × Clear all
NCT00012311 2014-01-06

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Breast

Breast Neoplasms

NCT00002498 2013-12-18

Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Breast

Breast Neoplasms

NCT00003680 2013-11-06

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
300 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00033683 2009-02-09

Combination Chemotherapy in Treating Women With Resected Breast Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡